Evaluation of a Therapeutic Mobile App for Depression

Not Applicable

Completed

• Conditions: Depression
• Interventions: Device: Gamified Placebo Training; Device: Gamified Attention Bias Modification

• Registration Number: NCT05601362
• Lead Sponsor: University of Texas at Austin

Brief Summary

The purpose of this study is a preliminary evaluation of a gamified attention bias modification training (GAMBT) for reducing symptoms of depression and rumination. Individuals with elevated symptoms of depression will use the digital intervention over the course of 4 weeks. They will complete a brief (\~5 question) survey daily, as well as weekly assessments.

Detailed Description

This study aims to assess the feasibility and efficacy of the digital therapeutic attention bias modification (ABM) intervention that targets and reduces negative attention bias among adults with elevated symptoms of depression. Consistent with the experimental therapeutics approach ABM has been shown to both reduce negative attention bias and improve symptoms of depression. However, engagement with these tasks have been mixed, with some participants describing traditional ABM tasks as boring. This had led to the development of gamified versions of ABM with the intent to improve participant engagement. Nevertheless, there have been very few rigorous trials of ABM for depression, and no one to our knowledge has used ecological momentary assessment to tease apart the mechanisms by which ABM can lead to improvements in depression symptoms.

Participants will access the intervention on their mobile smart phone and complete treatment over a period of 4 weeks. Enrolled participants will be randomly assigned to one of two groups: Gamified attention bias modification training, or gamified placebo training. They will complete brief (\~5 questions) daily surveys, as well as weekly remote assessments of attention bias and depression symptoms.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2022-10-26
• Study First Submitted QC: 2022-10-26
• Study First Posted: 2022-11-01
• Study Start: 2023-03-30
• Primary Completion: 2023-08-30
• Study Completion: 2023-08-30
• Status Verified: 2024-12
• Last Update Submitted: 2024-12-03
• Last Update Posted: 2024-12-06

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 110

Inclusion Criteria

• able and willing to provide informed consent;
• fluent in English;
• normal or corrected-to-normal vision
• moderate or greater depression symptoms (defined as greater than or equal to 10 on the PHQ-8);
• attention bias for negative stimuli (operationalized as greater than an average of 6500 ms of dwell time on sad faces in an attention bias task);
• stable psychiatric and neurological medication usage.
• access to a smartphone for downloading the app and a laptop or desktop computer to complete the weekly assessments

Read More

Exclusion Criteria

• recent heavy alcohol use defined as a score of 2 or higher on the PDSQ
• past or present comorbidity of other serious mental illness (e.g., schizophrenia, substance use disorder, bipolar disorder, etc.)
• previous experience with gamified attention bias modification app

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Gamified Placebo Training	Gamified Placebo Training	Identical version of the gamified behavioral intervention without manipulation designed to decrease negative attention bias
Gamified Attention Bias Modification	Gamified Attention Bias Modification	Digital therapeutic intervention based on Attention Bias Modification Training (ABMT) designed to decrease negative attention bias.

Primary Outcome Measures

Name	Time	Method
Patient Health Questionnaire - 8 (PHQ-8)	Baseline to Treatment End (4 weeks)	8-item self-report measure of depression symptom severity (Range: 0-24, higher scores indicate greater depression severity)

Secondary Outcome Measures

Name	Time	Method
Perseverative Thinking Questionnaire (PTQ) -"Difficult to Disengage from" subscale	Baseline to Treatment End (4 weeks)	3-item self-report measure of rumination frequency (Range: 0-12, higher scores indicate more rumination)
Ruminative Response Scale - Brooding subscale (RRS-B)	Baseline to Treatment End (4 weeks)	5-item self-report measure of rumination frequency (Range: 1-20, higher scores indicate more rumination)
Inventory of Depression and Anxiety Symptoms (IDAS) Dysphoria subscale	Baseline to Treatment End (4 weeks)	10-item measure of dysphoria and depression symptoms (Range: 10-50, higher scores indicate greater dysphoria)

Trial Locations

Locations (1)

Mary Eileen McNamara; 🇺🇸 Austin, Texas, United States